Aveanna Healthcare (AVAH) Expected to Announce Quarterly Earnings on Thursday

Key Points

• Aveanna Healthcare (AVAH) is set to report its Q2 2025 quarterly earnings on August 7th, with analysts predicting earnings of $0.04 per share and revenue of $535.34 million.
• The company recently saw its stock price decline by 0.7%, opening at $3.99. Its market capitalization stands at $778.41 million, with a P/E ratio of 199.50.
• A number of recent analyst reports have led to varying ratings for Aveanna Healthcare, including upgrades to "buy" from Jefferies and a target price increase to $5.00 by UBS Group.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) is anticipated to announce its Q2 2025 earnings results before the market opens on Thursday, August 7th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $535.34 million for the quarter.

Aveanna Healthcare Stock Performance

AVAH stock traded down $0.23 on Friday, reaching $3.74. The company's stock had a trading volume of 467,444 shares, compared to its average volume of 372,681. Aveanna Healthcare has a 12-month low of $2.61 and a 12-month high of $6.19. The firm has a market cap of $729.64 million, a PE ratio of 187.00 and a beta of 1.96. The business has a fifty day simple moving average of $4.67 and a two-hundred day simple moving average of $4.80.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder Paul R. Vigano sold 1,560,700 shares of Aveanna Healthcare stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $5.36, for a total transaction of $8,365,352.00. Following the transaction, the insider directly owned 29,640,756 shares of the company's stock, valued at $158,874,452.16. The trade was a 5.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 1,560,700 shares of the business's stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $5.36, for a total value of $8,365,352.00. Following the transaction, the insider owned 29,640,756 shares of the company's stock, valued at approximately $158,874,452.16. This trade represents a 5.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 7,115,345 shares of company stock worth $37,838,057. 7.80% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. AQR Capital Management LLC lifted its stake in shares of Aveanna Healthcare by 21.2% during the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company's stock valued at $142,000 after buying an additional 4,602 shares in the last quarter. Jane Street Group LLC boosted its stake in shares of Aveanna Healthcare by 522.0% in the first quarter. Jane Street Group LLC now owns 75,081 shares of the company's stock worth $407,000 after acquiring an additional 63,010 shares during the period. Finally, Goldman Sachs Group Inc. raised its stake in Aveanna Healthcare by 8.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company's stock valued at $1,842,000 after purchasing an additional 25,974 shares during the period. 87.96% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts recently issued reports on AVAH shares. Wall Street Zen lowered shares of Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 27th. Jefferies Financial Group raised shares of Aveanna Healthcare from a "hold" rating to a "buy" rating and decreased their target price for the company from $6.25 to $6.00 in a research note on Monday, July 21st. Barclays assumed coverage on shares of Aveanna Healthcare in a research report on Wednesday, July 2nd. They set an "equal weight" rating and a $5.50 price target for the company. Truist Financial lowered their price objective on Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating on the stock in a research report on Wednesday, July 16th. Finally, UBS Group lifted their target price on Aveanna Healthcare from $4.50 to $5.00 and gave the stock a "sell" rating in a report on Friday, May 9th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat, Aveanna Healthcare presently has a consensus rating of "Hold" and a consensus price target of $5.25.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.